{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"37","upperLimit":"69","value":"54"},{"groupId":"OG001","lowerLimit":"0","upperLimit":"14","value":"0"},{"groupId":"OG002","lowerLimit":"40","upperLimit":"70","value":"55"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"25"},{"groupId":"OG002","value":"47"}],"units":"Participants"}],"description":"ORR was used to determine whether MSI is a marker that predicts treatment response. This is the same data presented in outcome measure number 8 (ORR, to test against null of 5%).","dispersionType":"95% Confidence Interval","groups":[{"description":"MK-3475: MK-3475 10 mg/kg every 14 days","id":"OG000","title":"Cohort A: MSI Positive Colorectal Cancer"},{"description":"MK-3475: MK-3475 10 mg/kg every 14 days","id":"OG001","title":"Cohort B: MSI Negative Colorectal Cancer"},{"description":"MK-3475: MK-3475 10 mg/kg every 14 days","id":"OG002","title":"Cohort C: MSI Positive Non-Colorectal Cancer"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"28 months","title":"Does MSI as a Marker Predict Treatment Response","type":"SECONDARY","unitOfMeasure":"percentage of participants"}